James Wild MP: written questions
4 Jul 2026–16 Oct 2026 · year in progress
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Read what this MP said, asked and contributed in Parliament.
11 published records · newest first.
Written questions
Sodium Valproate and Surgical Mesh ImplantsDepartment of Health and Social CareTabled 7 Sept 2026AnsweredUIN 27562More
Question: To ask the Secretary of State for Health and Social Care, when she plans to respond to the Hughes Report on valporate and pelvic mesh.
Answer: I refer the Hon Member to the answer provided on 14 July in response to Question 16121.
Answered 14 Sept 2026
Original Parliament recordBrain: TumoursDepartment of Health and Social CareTabled 28 Aug 2026AnsweredUIN 21908More
Question: To ask the Secretary of State for Health and Social Care, what assessment she has made of the availability of specialist treatment services for patients diagnosed with low-grade glioma across England.
Answer: I refer the Hon Member to the answer provided to the Hon Member for Chingford and Woodford Green on 26 May 2026 in response to Question 1100.
Answered 7 Sept 2026
Original Parliament recordBrain: TumoursDepartment of Health and Social CareTabled 28 Aug 2026AnsweredUIN 21907More
Question: To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that funding decisions for brain tumour research reflect the prevalence and clinical impact of low-grade glioma.
Answer: Some of the data requested by the Hon. Member is not centrally held, but on the wider issues raised, I refer him to the answer provided on 3 March in response to Question 115098. Available data on this issue is also published by the National Institute for...
Answered 18 Sept 2026
Original Parliament recordBrain: TumoursDepartment of Health and Social CareTabled 28 Aug 2026AnsweredUIN 21906More
Question: To ask the Secretary of State for Health and Social Care, what estimate she has made of the annual NHS expenditure on the treatment and management of low-grade glioma patients in England.
Answer: I refer the Hon Member to the answer provided to the Hon Member for Chingford and Woodford Green on 26 May 2026 in response to Question 1100.
Answered 7 Sept 2026
Original Parliament recordBrain: TumoursDepartment of Health and Social CareTabled 28 Aug 2026AnsweredUIN 21905More
Question: To ask the Secretary of State for Health and Social Care, whether her Department plans to increase investment in research relating to low-grade glioma over the next spending period.
Answer: Some of the data requested by the Hon. Member is not centrally held, but on the wider issues raised, I refer him to the answer provided on 3 March in response to Question 115098. Available data on this issue is also published by the National Institute for...
Answered 18 Sept 2026
Original Parliament recordBrain: TumoursDepartment of Health and Social CareTabled 28 Aug 2026AnsweredUIN 21904More
Question: To ask the Secretary of State for Health and Social Care, what funding her Department has allocated to research into low-grade glioma in each of the last five years.
Answer: Some of the data requested by the Hon. Member is not centrally held, but on the wider issues raised, I refer him to the answer provided on 3 March in response to Question 115098. Available data on this issue is also published by the National Institute for...
Answered 18 Sept 2026
Original Parliament recordDepartment of Health and Social Care: Public ExpenditureDepartment of Health and Social CareTabled 13 Jul 2026AnsweredUIN 18154More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 July 2026 to Question 15445 on Department of Health and Social Care: Public Expenditure, if she will set out which capital programmes have been identified as having fle
Answer: Capital budgets are managed flexibly within the Department's overall capital expenditure limits to maximise delivery against agreed priorities and outcomes.The Department does not routinely identify specific programmes in advance for the redeployment of c...
Answered 16 Jul 2026
Original Parliament recordCJD: ResearchDepartment of Health and Social CareTabled 8 Jul 2026AnsweredUIN 17030More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research to identify a cure for Creutzfeldt-Jakob disease.
Answer: The Department commissions research through the National Institute for Health and Care Research (NIHR) and invests over £1.8 billion a year on applied health and care research. The NIHR welcomes funding applications for research into any aspect of human h...
Answered 16 Jul 2026
Original Parliament recordBreast Cancer: DrugsDepartment of Health and Social CareTabled 7 Jul 2026AnsweredUIN 16589More
Question: To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential merits of introducing Enhertu for use in the NHS.
Answer: I refer the hon. Member to the answer I gave to the hon. Member for South Basildon and East Thurrock on 29 June 2026 to Question 11564.
Answered 15 Jul 2026
Original Parliament recordBreast Cancer: DrugsDepartment of Health and Social CareTabled 7 Jul 2026AnsweredUIN 16588More
Question: To ask the Secretary of State for Health and Social Care, what discussions his Department has had with AstraZeneca and Diiachi Sankyo on making Enhertu breast cancer drugs viable for introduction to the NHS.
Answer: I refer the hon. Member to the answer I gave to the hon. Member for South Basildon and East Thurrock on 29 June 2026 to Question 11564.
Answered 15 Jul 2026
Original Parliament recordBreast Cancer: DrugsDepartment of Health and Social CareTabled 7 Jul 2026AnsweredUIN 16587More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department has taken to make Enhertu breast cancer drugs available to the NHS.
Answer: I refer the hon. Member to the answer I gave to the hon. Member for South Basildon and East Thurrock on 29 June 2026 to Question 11564.
Answered 15 Jul 2026
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2026–16 Oct 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →